drugset / Trial / NCT04859283

Premedication with Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty

NCT04859283 ↗

Phase 4 Completed 100 enrolled Turku University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to find out if preoperatively given dexmedetomidine is effective analgesic adjuvant for treating postoperative pain in patients undergoing elective total knee arthroplasty (TKA). Another aim is to determine if premedication with intranasal dexmedetomidine could provide sufficient sedation to alleviate anxiety during TKA.

Timeline

Start
2022-06-10
Primary completion
2023-09-15
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intranasal